Advanced or metastatic gastric cancer
Clinical trials for Advanced or metastatic gastric cancer explained in plain language.
Never miss a new study
Get alerted when new Advanced or metastatic gastric cancer trials appear
Sign up with your email to follow new studies for Advanced or metastatic gastric cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A targeted drug takes aim at a Hard-to-Treat stomach cancer
Disease control Stopped earlyResearchers are testing an experimental drug called MRG003 in adults with advanced gastric or gastroesophageal junction cancer that has spread or cannot be removed by surgery. The trial enrolls people whose tumors test positive for EGFR and negative for HER2, a combination that l…
Matched conditions: ADVANCED OR METASTATIC GASTRIC CANCER
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Cancer drug trial halted early – what happened?
Disease control Stopped earlyThis phase 2 trial tested the drug futibatinib in 115 people with advanced solid tumors or blood cancers that have specific FGFR gene changes. The goal was to see if the drug could shrink tumors or cause remission. The study was terminated early, so final results are not yet clea…
Matched conditions: ADVANCED OR METASTATIC GASTRIC CANCER
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC